Back to Fotmer Life Sciences or All Flower/Bud

Terpene Profile (Strain Estimate)

Alpha-PineneMajorPine/Sharp156℃
Beta-PineneMajorPine/Herbal165℃
MyrceneMajorHerbal/Musk166-168℃
CaryophylleneMajorPepper/Spice119℃

MedBud currently tracks 16 common terpenes, more will be added.

Medication Details

Brand
Uruguay Fotmer Life Sciences
Designation
T3s T21
Cultivar/Strain
Red Dragon
Classification
Chemotype
Type I: High THC
THC Potential Range (±10%)
21%
CBD Potential Range (±10%)
<1%
Cultivated/Produced by
Uruguay Fotmer Life Sciences
Cultivated in
Flag of Uruguay Uruguay
Packaged in
Flag of Germany Germany
Imported by
Germany Cantourage
Irradiation
Non-Irradiated
Flower Provided
Whole Flower

Stock Availability

We provide stock and pharmacy information for medical cannabis patients only. Cannabis is a controlled substance in the UK and can only be dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed here.

Best Known Status: Launch Delay

Main Partner Pharmacy

Pharmacy Wholesaler

Dispensing Pharmacies

Product DescriptionPatient Reviews

Uruguay About Fotmer Life Sciences Uruguay

Fotmer Life Sciences Logo

Established in Uruguay and strong relationships across North America, the European Union and Middle East, Fotmer is well positioned to dominate the global cannabis cultivation market through its low-cost production capacity and international transportation infrastructure.

Fotmer Life Sciences is a medical cannabis cultivator & extractor and one of the world’s largest Good Agricultural Collection Practice (GACP) and Uruguayan-GMP certified global cannabis exporters.

With strategic assets established in Uruguay and strong relationships across North America, the European Union and Middle East, Fotmer is well positioned to dominate the global cannabis cultivation market through its low-cost production capacity and established international transportation infrastructure.

fotmer.com

  New government petition approved: Introduce 'Grow Your Own' Laws for Legal Medical Cannabis Patients (CBPM) — please sign and share. 6 months to achieve 10,000 signatures.

  Information provided is partially community-sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)